Telomeres, the natural ends of linear eukaryotic chromosomes, are essential for cell viability and genome integrity. In most organisms, telomeric DNA consists of short repetitive sequences that terminate in 3′ single-stranded overhangs. Both the double-stranded repeats and the 3′ overhangs of mammalian telomeres are bound by shelterin, a six-protein complex that exclusively associates with telomeres and protects chromosome ends from aberrant DNA repair activities 1,2 . Telomeric proteins have undergone a rapid rate of change during evolution 3 . Notably, RAP1 is the only telomere protein that is conserved from budding and fission yeast to mammals. RAP1 contains a BRCT domain, one or two Myb domains and an RCT domain (Fig. 1a) . Despite this relatively conserved multidomain architecture, RAP1 proteins in different organisms seem to have acquired diversified functions during evolution.
Telomeres, the natural ends of linear eukaryotic chromosomes, are essential for cell viability and genome integrity. In most organisms, telomeric DNA consists of short repetitive sequences that terminate in 3′ single-stranded overhangs. Both the double-stranded repeats and the 3′ overhangs of mammalian telomeres are bound by shelterin, a six-protein complex that exclusively associates with telomeres and protects chromosome ends from aberrant DNA repair activities 1, 2 . Telomeric proteins have undergone a rapid rate of change during evolution 3 . Notably, RAP1 is the only telomere protein that is conserved from budding and fission yeast to mammals. RAP1 contains a BRCT domain, one or two Myb domains and an RCT domain (Fig. 1a) . Despite this relatively conserved multidomain architecture, RAP1 proteins in different organisms seem to have acquired diversified functions during evolution.
In mammalian cells, RAP1 is the least well-understood component of the shelterin complex. Mammalian RAP1 does not directly bind to telomeric DNA. Instead, it is recruited to telomeres through interaction between its C-terminal RCT domain and TRF2, another shelterin protein that binds to the duplex region of telomeres 4 . TRF2 is essential in telomere end protection because removal of TRF2 from telomeres initiates a potent DNA damage response (DDR) that activates the nonhomologous end-joining (NHEJ) pathway, leading to massive end-to-end chromosome fusions [5] [6] [7] [8] [9] . Human RAP1 has been suggested to have a key role in suppressing NHEJ 10, 11 . However, two recent reports have shown that mouse Rap1 seems dispensable for suppression of NHEJ at telomeres 12, 13 . Instead, Rap1 is critical for the repression of homology-directed repair (HDR) at telomeres. Thus, it remains unclear whether RAP1 is required to protect telomeres from NHEJ.
Budding yeast Saccharomyces cerevisiae Rap1 (ScRap1) was discovered as a positive transcriptional regulator of genes for multiple growth-related genes 14 . Later studies showed that ScRap1 is the major double-stranded telomeric repeat-binding protein in S. cerevisiae and has essential roles in telomere length regulation, subtelomeric gene silencing and chromosome end protection 15 . Whereas the central two Myb domains are responsible for the DNA-binding activity of ScRap1 (ref. 16 ), the C-terminal RCT domain mediates chromatin recruitment of two sets of proteins, the Sir proteins (Sir3 and Sir4) for transcriptional silencing 17, 18 and the Rif proteins (Rif1 and Rif2) for telomere length regulation 19 . Although the crystal structure of ScRap1 RCT is available 20 , how this domain recruits the Sir and the Rif proteins to telomeres still remains unknown.
Fission yeast Schizosaccharomyces pombe Rap1 (SpRap1) was identified on the basis of its limited sequence similarity to ScRap1 (refs. 21,22) . Like mammalian RAP1 but unlike ScRap1, SpRap1 lacks DNA-binding activity and was thought to localize to telomeres via interactions with Taz1, an ortholog of mammalian TRF1 and TRF2 (refs. 21,22) . Deletion of fission yeast rap1 leads to chromosome 2 1 4 VOLUME 18 NUMBER 2 FEBRUARY 2011 nature structural & molecular biology a r t i c l e s end-to-end fusions, telomere elongation and derepression of telomere silencing, phenotypes reminiscent of those observed in taz1∆ cells, suggesting a close relationship between SpRap1 and Taz1 (ref. 23 ). However, SpRap1 lacks an obvious RCT domain. Therefore, how SpRap1 interacts with Taz1 remains unclear.
To address these structural and functional questions about RAP1, we solved the three-dimensional crystal or solution structures of the RCT domains of human and budding yeast RAP1, and a putative RCT domain of SpRap1, in complex with their respective binding partners, TRF2, Sir3 and Taz1. Our studies show that RAP1 contains a conserved protein-protein interaction module that has diverse roles at telomeres in different organisms.
RESULTS

Structure of the human TRF2 RBM -RAP1 RCT complex
TRF2 is required for the recruitment of RAP1 to telomeres. A central fragment of TRF2, TRF2 , binds to the RCT domain of RAP1, RAP1 (ref. 4) . To further map the RAP1-binding region of TRF2, we evaluated the ability of various fragments of TRF2 to interact with RAP1. The fragment TRF2 275-316 was necessary and sufficient for binding with RAP1 RCT (Fig. 1a and Supplementary Fig. 1a ). TRF2 binds to RAP1 RCT with a K d of 16.5 nM, similar to that for binding of full-length TRF2 to RAP1 RCT (23.9 nM) as measured by isothermal titration calorimetry (ITC) (Figs. 1b and 2e) . Hereafter, we refer to TRF2 275-316 as TRF2 RBM (RAP1-binding motif) (Fig. 1a) .
To determine the structural basis of RAP1 recognition by TRF2, we crystallized the TRF2 RBM -RAP1 RCT complex and solved its structure by SAD ( Table 1) . RAP1 RCT consists of six α-helices arranged in two three-helix bundles (Fig. 1c) . The structure of RAP1 RCT closely resembles that of the RCT domain of budding yeast S. cerevisiae Rap1 (ScRap1 RCT ), consistent with previous sequence alignment predictions (Fig. 1d) 4, 20 . Indeed, an unbiased search for structurally homologous proteins showed that the structure of RAP1 RCT is most similar to that of ScRap1 RCT , with a r.m.s. deviation of 2.3 Å (Fig. 1d) . In addition to the structurally conserved three-helix bundles, ScRap1 RCT contains an N-terminal extension covering one side of the RCT domain, which is not present in RAP1 RCT (Fig. 1d) .
TRF2 RBM is a helix-turn-helix motif that packs against helices α1 and α2 of RAP1 RCT to form an intermolecular four-helix bundle (Fig. 1c) . The formation of the complex causes the burial of 2,400 Å 2 of surface area at the interface. The driving force for the binding of TRF2 to RAP1 is van der Waals interactions (Fig. 1e) . Helix α1 of TRF2 RBM contributes most of the hydrophobic contacts. Hydrophobic residues of TRF2 RBM from helix α1 make extensive contacts with the hydrophobic wedge between helices α1 and α2 of RAP1 RCT (Fig. 2a) . Helix α2 of TRF2 RBM makes less direct hydrophobic contact with RAP1. Instead, its C terminus mediates four intermolecular electrostatic interactions with RAP1 (Fig. 2b) . In addition to helices α1 and α2, the terminal regions of TRF2 RBM also contribute to the binding to RAP1. They function as the two arms of a clamp to hold helix α2 of RAP1 RCT (Fig. 1c and Supplementary Fig. 1b) . The N-terminal a r t i c l e s tail of TRF2 RBM extends into a deep groove of RAP1 and runs antiparallel to loop L 23 , between helices α2 and α3 of RAP1 RCT (Fig. 2c) . The C-terminal tail of TRF2 RBM contacts the other side of RAP1 RCT ( Fig. 1c and Supplementary Fig. 1b) ; the side chains of TRF2 Leu313 and Leu315 pack against a hydrophobic patch of RAP1 RCT formed by residues from loop L 34 and helices α2 and α3 (Fig. 2b) .
Mutational and functional analyses of TRF2 RBM -RAP1 RCT
To corroborate our structural analysis, we focused on the hydrophobic interface between TRF2 RBM and RAP1 RCT . At the center of this interface, the side chain of Leu288 of TRF2 is nested in a pocket formed by a group of hydrophobic residues of RAP1 (Fig. 2d) . TRF2 L288R mutation completely abolished the interaction with RAP1 in both ITC and yeast two-hybrid assays ( Fig. 2e and Supplementary Fig. 2a,b) . Similarly, RAP1 mutations I318R and F336R on the other side of the interface also impaired the interaction ( Fig. 2e and Supplementary  Fig. 2a,b) . To further examine the TRF2-RAP1 interaction in vivo, we next studied the interactions of mutant proteins transiently expressed in human embryonic kidney 293T cells. Consistent with the ITC and yeast two-hybrid analyses, coimmunoprecipitation experiments showed that mutations of the key hydrophobic residues at the interface completely abolished the TRF2-RAP1 interaction in cells (Fig. 2f) . To confirm that these point mutations affected only TRF2's interaction with RAP1, we cotransfected wild-type TRF2 and TRF2 L288R with the TRF2-interacting protein Apollo in 293T cells. Consistent with the previous finding that Apollo is recruited to telomeres by its interaction with the TRF homology (TRFH) domain of TRF2 (ref. 24) , Apollo was efficiently coimmunoprecipitated by both wild-type TRF2 and TRF2 L288R (Supplementary Fig. 2c ). Taken together, our mutagenesis analyses suggest that the hydrophobic interface is necessary for both in vitro and in vivo binding of RAP1 to TRF2.
To examine the role of TRF2 in targeting RAP1 to telomeres in cells, we investigated whether telomeric accumulation of RAP1 depends on its interaction with TRF2. Indirect immunofluorescence of HeLa cells transiently transfected with hemagglutinin (HA)-tagged RAP1 showed that, whereas wild-type RAP1 showed a nuclear punctate staining pattern that completely colocalized with telomeric DNA, both the RAP1 I318R and F336R mutants were distributed diffusely throughout the nucleoplasm ( Fig. 2g and Supplementary Fig. 2d ). Next, we cotransfected wild-type RAP1 together with TRF2 L288R and assayed for subcellular localization of both proteins. Although TRF2 L288R efficiently localized to telomeres (Supplementary Fig. 2e ), it did not recruit exogenous RAP1 to telomeres (Fig. 2h) , indicating that overexpression of TRF2 L288R has a dominant negative effect on RAP1's ability to localize to telomeres. In contrast, telomeric localization of Apollo was still retained in the presence of TRF2 L288R, consistent with the observation that Apollo is recruited to telomeres through its interaction with TRF2 TRFH (Fig. 2h) . Notably, all the RAP1 proteins were overexpressed at comparable levels in cells with different combinations of TRF2 and RAP1 mutations (Supplementary Fig. 2f ).
Collectively, these results demonstrate that telomeric localization of RAP1 depends on its direct interaction with TRF2.
To further investigate the in vivo importance of the TRF2-RAP1 interaction, we first depleted endogenous mouse Terf2 (also known as Trf2) using retrovirus-mediated short hairpin RNA (shRNA) in SV40LT-immortalized mouse embryonic fibroblasts (MEFs) (Supplementary Fig. 3a ) 25 . When Trf2 is compromised, telomeres initiate a robust Ataxia telangiectasia mutated (ATM)-dependent DNA damage response, leading to phosphorylation of Chk2 and the induction of 'telomere dysfunction-induced foci' (TIFs) (Fig. 3a,b and Supplementary Fig. 3a ) 5, 9, 25 . Metaphase spreads showed that almost all the telomeres are joined together, leading to long trains of fused a r t i c l e s chromosomes ( Fig. 3c,d ). This telomere deprotection phenotype was nearly completely rescued by retroviral transduction of an shRNAresistant Trf2 cDNA in MEFs before Trf2 shRNA treatment ( Fig. 3a-d) .
We investigated whether the telomere deprotection phenotype caused by Trf2 depletion could be rescued upon introduction of an shRNAresistant Trf2 mutant deficient in Rap1 binding (Trf2 L286R). Trf2 L286R is equivalent to human TRF2 L288R, which does not bind to RAP1 (Fig. 2e,f) . Although Trf2 L286R localized efficiently to telomeres ( Supplementary Fig. 3b ), endogenous Rap1 did not accumulate at telomeres when Trf2 L286R was expressed ( Supplementary Fig. 3c ).
In fact, the protein levels of endogenous Rap1 were greatly reduced in Trf2 shRNA (shTrf2)-treated MEFs with or without the expression of Trf2 L286R (Supplementary Fig. 3a ). In contrast, expression of wildtype Trf2 restored endogenous Rap1 to a level comparable to that in control cells (Supplementary Fig. 3a) . These results were consistent with a previous study 5 , indicating that the Trf2-Rap1 interaction not only was required for targeting Rap1 to telomeres but also was critical for the stability of endogenous Rap1. Expression of Trf2 L286R in shTrf2-treated MEFs largely rescued TIF formation (Fig. 3a,b) , suggesting that Rap1 is not required to repress the DDR at telomeres. Unlike the massive end-to-end chromosome fusions with robust telomeric signals at fusion sites when Trf2 is removed 5, 25 , replacement of endogenous Trf2 with Trf2 L286R led to end-to-end chromosome fusions involving ~13% of all chromosome ends (Fig. 3c,d ). These data suggest that Rap1 does not participate in inhibition of NHEJ-mediated fusions at telomeres. Notably, the chromosome fusion sites in shTrf2-treated MEFs expressing Trf2 L286R were largely devoid of telomeric signals (Fig. 3c,d ). To further examine the relationship between Rap1 and this telomere loss, we fused rap1 with shRNA-resistant Trf2 L286R and complemented this chimeric DNA into MEFs before Trf2 shRNA treatment (Supplementary Fig. 4a ). The telomere attrition phenotype was completely rescued in response to Rap1-Trf2 L286R expression ( Supplementary Fig. 4b-d) , confirming that the observed telomere attrition phenotype in Trf2 L286R-expressing cells was caused by the lack of Rap1 at telomeres.
Aberrant HDR at telomeres could lead to the deletion of telomeric DNA 26, 27 , enabling end-to-end chromosome fusions with fusion sites lacking telomeric signals. To test whether Rap1 is required to repress telomere attrition owing to inappropriate HDR at telomeres, we visualized both leading-and lagging-strand telomeres and analyzed telomere sister chromatid exchanges (T-SCEs) using chromosome-orientation FISH (CO-FISH) 28 . Both control metaphases and metaphases from Trf2-expressing MEFs devoid of endogenous Trf2 showed low levels of T-SCEs (Fig. 3e,f) . In contrast, metaphases from cells expressing Trf2 L286R showed a marked increase in T-SCEs (Fig. 3e,f) . Our results therefore indicate that Rap1 is required to represses aberrant HDR at telomeres, consistent with two recent studies 12, 13 .
Structural basis of fission yeast Taz1-SpRap1 interaction
Fission yeast SpRap1 has an important role in telomere length homeostasis and telomere protection [21] [22] [23] . Similar to mammalian RAP1, SpRap1 also associates with the double-stranded telomeric DNAbinding protein Taz1 (refs. 21,22) . However, unlike its budding yeast and mammalian counterparts, SpRap1 lacks a recognizable RCT domain 21, 22 . To determine the mechanism of SpRap1 interaction with Taz1, we evaluated various fragments of SpRap1 and Taz1 for their interaction by gel filtration chromatography (data not shown). Our data show that, similar to the mammalian TRF2-RAP1 interaction, the C terminus of SpRap1 (residues 639-693) is sufficient for interaction with a short fragment of Taz1 (residues 365-396) (Fig. 4a) . Hereafter, Taz1 365-396 and SpRap1 639-693 are referred to as Taz1 RBM and SpRap1 RCT , respectively (Fig. 4a) . Taz1 RBM binds to SpRap1 RCT with a K d of 2.0 µM (Fig. 4b) . 
a r t i c l e s
To determine the structural basis of SpRap1 recognition by Taz1, we reconstituted the Taz1 RBM -SpRap1 RCT complex and determined its solution structure by NMR (Supplementary Fig. 5a ,b and Table 2 ). To simplify the NMR sample preparation, we linked SpRap1 RCT to Taz1 RBM with a 14-residue linker. The linker is flexible and long enough that it does not influence the proper interaction between Rap1 RCT and Taz1 RBM (Supplementary Fig. 5c,d) . The structure of the Taz1 RBM -SpRap1 RCT complex shows a compact globular fold (Fig. 4c) . Taz1 RBM contains a single α-helix, whereas SpRap1 RCT consists of three helices (Fig. 4c) . Together, these helices are arranged into an intermolecular four-helix bundle. The Taz1 RBM -SpRap1 RCT interface buries ~1,680 Å 2 of solvent-accessible surface area (Fig. 4d) , which is substantially less than the interface area between human TRF2 RBM and RAP1 RCT . This is consistent with the much weaker binding affinity between Taz1 RBM and SpRap1 RCT (Fig. 4b) .
To our surprise, the structure of SpRap1 RCT closely resembles the N-terminal three-helix bundle of the RCT domain of human RAP1 (Fig. 4d) . On the basis of amino acid sequence alignment alone, the presence and extent of the RCT domain of SpRap1 could not have been correctly predicted (Fig. 4e) . Notably, the structural similarity is not only limited to Rap1 RCT ; the Taz1 RBM helix interacts with SpRap1 RCT markedly similarly to the α1 helix of TRF2 RBM in the TRF2 RBM -Rap1 RCT complex (Fig. 4d) . The hydrophobic portion of the Taz1 RBM helix packs into a hydrophobic groove formed by helices α1 and α2 of SpRap1 RCT . Similar to Leu288 in human TRF2 RBM , the side chains of Ile379 and Leu383 of Taz1 point into the hydrophobic groove of SpRap1 RCT (Fig. 4d) . Although the Taz1 RBM -SpRap1 RCT interface is predominantly hydrophobic, electrostatic interactions provide additional specificity and stability to the complex. At both sides of the Taz1 RBM helix, the side chains of Arg384 and Arg386 mediate a total of six electrostatic interactions with SpRap1, helping anchor the Taz1 RBM helix into the hydrophobic groove of SpRap1 RCT ( Fig. 4d and Supplementary Fig. 5e ). Despite the fact that Taz1 RBM lacks the second helix (α2) in TRF2 RBM (Fig. 4f) , the marked structural similarity between Taz1 RBM -SpRap1 RCT and TRF2 RBM -RAP1 RCT supports the notion that the interaction between Rap1 and the doublestranded telomeric DNA-binding protein is evolutionarily conserved from fission yeast to higher eukaryotes.
Mutational and functional analyses of the Taz1-SpRap1 interface
To investigate the importance of the Taz1-SpRap1 interaction, we first used ITC to measure the binding of a panel of missense mutations targeting interacting residues in both Taz1 RBM and SpRap1 RCT . The mutations Taz1 I379R, Taz1 L383R and SpRap1 I655R at the center of the interface completely abolished Taz1 RBM -SpRap1 RCT interaction (Fig. 5a) . In contrast, three mutations at the periphery region of the interface (Taz1 L380R, Taz1 V387R and Rap1 V651R), which contribute less to the interaction, only weakened but did not disrupt the interface (Figs. 4d and 5a) . We confirmed the effects of these mutants by yeast two-hybrid assays (Fig. 5b) . Furthermore, mutants Taz1 R384E and Taz1 R386E, designed to eliminate the electrostatic contacts between Taz1 and SpRap1 (Fig. 4d) , either completely abrogated or greatly weakened the interaction (Fig. 5b) . Taken together, these results demonstrate that both hydrophobic and electrostatic interactions are crucial for formation of the Taz1-SpRap1 complex. 
To address the in vivo consequences of the Taz1-SpRap1 interaction in telomere maintenance and protection, we first analyzed the telomere length phenotypes of the Taz1 and SpRap1 mutants that disrupted the Taz1-SpRap1 interaction to varying degrees in ITC assays (Supplementary Table 1) . All the mutant proteins were expressed at near wild-type levels in S. pombe cells ( Supplementary  Fig. 6a,b) . Consistent with the published results, deletion of the taz1 + or rap1 + genes led to a marked increase in telomere length and length heterogeneity (Fig. 5c) . Notably, all of the mutants showed partial or complete loss of telomere length regulation, in a manner consistent with the severity of the Taz1-SpRap1 interaction defect (Fig. 5a,c) . To analyze how the Taz1-SpRap1 interaction contributes to telomere end protection, we next examined the frequency of NHEJ-dependent telomere fusions at the G1 phase when homologous recombination is inhibited, as detected by pulsed-field gel electrophoresis of NotI-digested chromosomal DNA (Fig. 5d) . Mutants (Taz1 I379R, Taz1 L383R and SpRap1 I655R) with no detectable Taz1-SpRap1 interaction showed altered mobility bands representing intrachromosome fusions (Fig. 5e) . In comparison, mutants (Taz1 L380R, Taz1 V387R and SpRap1 V651R) that maintained partial Taz1-SpRap1 interaction activity protected telomeres from fusions (Fig. 5e) , suggesting that these weakened Taz1-SpRap1 interactions can still mediate end protection. Taken together, these studies indicate that the Taz1 RBM -SpRap1 RCT interaction is essential for telomere end protection and maintenance.
Next, to examine whether the observed telomere defects were caused by the failure of telomere targeting of SpRap1 by Taz1, we analyzed the cellular localization of SpRap1 in interphase cells expressing mutant Taz1-mCherry and SpRap1-GFP proteins. To our surprise, microscopic data showed that all the SpRap1 and Taz1 mutations, including those that completely disrupted the Taz1-SpRap1 interaction, only moderately decreased the frequency of SpRap1 recruitment to telomeres (Supplementary Fig. 6c-e) , indicating that the binding of SpRap1 to Taz1 is important but not the only mechanism for targeting SpRap1 to telomeres. Unlike mammalian RAP1, which only binds to TRF2 at telomeres, SpRap1 interacts with two telomeric proteins, Taz1 and Poz1, simultaneously 29 . Therefore, both Taz1 and Poz1 can probably recruit SpRap1 to telomeres. Consistent with this idea, SpRap1 localization was substantially reduced in poz1∆ cells, and was completely lost in taz1∆poz1∆ cells (Supplementary Fig. 6c,e) . Collectively, these data suggest that the interaction between Taz1 and SpRap1 has an important (but not essential) role in targeting SpRap1 to telomeres, and that the Taz1-SpRap1 interaction itself has a more direct role in regulation and protection of telomeres than has been thought. 
r t i c l e s
Structure and function of budding yeast Sir3-ScRap1 interaction
The budding yeast ScRap1 protein has multiple roles in telomere maintenance and transcription regulation 15 . Unlike mammalian and fission yeast RAP1 proteins, ScRap1 localizes to telomeres by direct DNA binding to TG 1-3 repeats through its two Myb domains 16 . ScRap1 mediates silencing at telomeres and at the silent HM matingtype loci by recruiting the Sir3 and Sir4 proteins via its C-terminal RCT domain (Fig. 6a) 17 . A short fragment of Sir3 (residues 456-481, referred to as Sir3 RBM ) is sufficient to mediate a yeast two-hybrid interaction with ScRap1 RCT (Fig. 6a) 17 . The K d for binding between Sir3 RBM and ScRap1 RCT is ~2.5 µM (Fig. 6b) , comparable to that of the fission yeast Taz1 RBM -SpRap1 RCT interaction (Fig. 4b) . Despite the lack of apparent sequence similarity between Sir3 RBM and either TRF2 RBM or Taz1 RBM , our findings that both mammalian and fission yeast RAP1 proteins use their RCT domains to recognize a short helical region of their interacting partners (Figs. 1c  and 4c ) prompted us to ask whether ScRap1 RCT uses the same mechanism to bind to Sir3 RBM . To test this hypothesis, we crystallized the Sir3 RBM -ScRap1 RCT complex and solved its structure by molecular replacement ( Table 1) . To our surprise, the structure of the complex shows a 2:1 stoichiometry between ScRap1 RCT and Sir3 RBM in the asymmetric unit (Supplementary Fig. 7a ). Both ScRap1 RCT molecules exhibit the same conformation as the unliganded ScRap1 RCT structure ( Fig. 6c and Supplementary Fig. 7a ) 20 . The central region of Sir3 RBM adopts a helical conformation, which together with the N-terminal extension interacts with one ScRap1 RCT molecule in the asymmetric unit, whereas the C terminus of Sir3 RBM (residues 461-464) contacts the other ScRap1 RCT (Supplementary Fig. 7a ). ITC measurements using Sir3 RBM peptides lacking either the N-or C-terminal tails showed that the Sir3 RBM C terminus is dispensable for ScRap1 RCT interaction (Supplementary Fig. 7b) . Thus, the second interaction mode between ScRap1 RCT and Sir3 RBM is probably due to lattice packing effects. We will focus our subsequent analysis on the first interaction mode.
The binding mode of Sir3 RBM to ScRap1 RBM closely resembles the interactions between TRF2 RBM and RAP1 RCT and between Taz1 RBM and SpRap1 RCT (compare Figs. 1c, 4c and 6c) . The Sir3 RBM helix packs against a hydrophobic groove formed by helices α1 and α2 of ScRap1 RCT (Fig. 6d,e) . The formation of the complex causes the burial of ~1,700 Å 2 of surface area at the interface. The side chain of Sir3 Ile463 (equivalent to TRF2 Ile283) is surrounded by a group of hydrophobic residues of ScRap1 (Fig. 6e) , whose equivalent residues in mammalian and fission 
a r t i c l e s yeast RAP1 proteins also have important roles in the TRF2 RBM -RAP1 RCT and Taz1 RBM -SpRap1 RCT interactions (Fig. 4e) . The crystal structure of the Sir3 RBM -ScRap1 RCT complex is corroborated by mutagenesis. Mutations of the hydrophobic residues at the interface either completely abolished or greatly weakened the binding of the Sir3 RBM helix to ScRap1 RCT (Fig. 6f) . To further examine the function of the Sir3 RBM -ScRap1 RCT interaction, we tested the effects of two ScRap1 mutants (A733R and G760R) that disrupt the Sir3-binding groove of ScRap1 on telomeric silencing (Fig. 6e,f  and Supplementary Fig. 7c ). We used a standard assay in which the URA3 gene is placed immediately next to telomere VII-L created at the ADH4 locus 30 . Both mutants showed a strong loss of silencing, as manifested by a >1,000-fold decrease in the ability to form colonies on medium containing 5-fluoroorotic acid (5-FOA), a drug that kills cells expressing the URA3 gene (Fig. 6g) 31 . Next, the effects on mating-type silencing by the same two ScRap1 mutants were assayed in a strain in which the TRP1 gene replaced the mating-type genes adjacent to a mutated HMR-E silencer element (HMR∆AøTRP1) 32 . Both rap1 mutations caused minor derepression of this silent locus, as indicated by a slight increase in growth on medium lacking tryptophan (Fig. 6g) . This marked difference in the effect of the rap1 mutations in telomeric versus HM silencing probably reflects the well-established redundancy of the HMR silencers 17 . On the basis of these results, we conclude that the Sir3 RBM -ScRap1 RCT interaction has an important role in telomeric silencing but is less important in mating-type silencing, in which other pathways for Sir protein recruitment probably compensate for the loss of this interaction.
DISCUSSION
RAP1 and TRF2 have distinct roles in telomere protection
Our structural, biochemical and cell biology data support a model in which mammalian TRF2 and RAP1 have important but distinct roles in telomere end protection. TRF2 inhibits classical NHEJ-mediated repair of telomeres and is also required to recruit RAP1 and other telomere associated proteins to telomeres 2 . RAP1 is required to repress HDR-mediated telomere recombination but is dispensable for preventing classical NHEJ-mediated repair of uncapped telomeres (Fig. 3c,d) . Our data also indicate that neither TRF2 nor RAP1 alone can fully protect telomeres. Instead, we propose that TRF2 and RAP1 form a stable heterodimer to protect the duplex region of telomeres.
A notable consequence of loss of protective functions at telomeres after removal of mouse Rap1 from telomeres is that chromosome endto-end fusions form without telomeres at fusion sites in metaphase chromosomes (Fig. 3c,d ). This fusion phenotype is distinct from the telomere fusions observed when Trf2 is removed from telomeres, in which robust telomeric signals are abundant at fusion sites 25 . Loss of Trf2 from telomeres probably disrupts the entire protective nucleoprotein structure so that telomeres are subjected to classical NHEJmediated fusions immediately after Trf2 loss 33 . In contrast, loss of Rap1 induces telomere attrition through activation of telomere HDR, leading to rapid telomere loss and subsequent joining of ends to form fusion sites devoid of telomeric sequences. Although the mechanism of Rap1 repression of telomere HDR is currently unclear, we postulate that either Rap1 directly inhibits telomere HDR or that Rap1 interacts with factor(s) involved in repressing telomere HDR.
Our observation of increased telomere recombination when Rap1 fails to localize to telomeres is consistent with two recent studies in which endogenous mouse Rap1 was conditionally deleted in MEFs 12, 13 . However, these studies did not report any telomere fusions when Rap1 was conditionally deleted in Rap1 F/F MEFs. We postulate that chromosome fusions were observed in our experimental setting because of efficient depletion of endogenous Trf2 through a robust shRNA-based approach 25 . Chromosome fusions probably arose in cells in which endogenous Trf2 was nearly completely depleted and functionally replaced by Trf2 L286R, leading to telomeres devoid of Rap1. Cre-mediated deletion of the conditional Rap1 allele probably cannot achieve the same level of efficiency because even in the best scenario Cre-mediated deletion of targeted alleles in MEFs approaches only 90% 34 .
Our finding that mammalian RAP1 by itself could not inhibit NHEJ at telomeres contrasts with a previous study, in which human RAP1 was found to prevent NHEJ at telomeres independent of TRF2 (ref. 11). We suggest that this difference in RAP1 function is probably due to the use of a dominant-negative form of TRF2 (TRF2 ∆B∆M ) to sequester endogenous RAP1 from telomeres in the previous study. TRF2 ∆B∆M interacts with endogenous TRF2 to form heterodimeric complexes that cannot interact with telomeres. However, a substantial fraction of endogenous TRF2 is still available at telomeres in cells expressing TRF2 ∆B∆M (refs. 9,35,36) . This residual telomere-associated TRF2 probably interacts with the RAP1-Teb1 chimeric protein used in this experimental setup to elicit telomere end protection 11 .
A conserved protein-protein interaction module
More than a decade of structural and functional studies have shown that the oligonucleotide-oligosaccharide binding (OB) folds and the Myb domains are evolutionarily conserved motifs used by telomere proteins to bind to single-stranded or double-stranded telomeric DNAs 16, [37] [38] [39] [40] [41] . However, it is not known whether evolutionarily conserved protein-protein interaction motifs also exist among telomere proteins. In this study, by using comparative structural analysis of RAP1 proteins from diverse organisms, we uncovered an evolutionarily conserved protein-protein interaction module, the RCT domain of RAP1. Our studies indicate that the RCT domains of both mammalian and fission yeast RAP1 mediate interactions with another telomere-binding protein (TRF2 in mammals; Taz1 in fission yeast) for chromosome end protection. In contrast, budding yeast ScRap1 RCT recruits Sir3 to telomeres for transcriptional silencing. These results thus highlight the notable functional plasticity of this structurally conserved motif. Given the almost undetectable sequence similarity among some of the RCT domains and their binding partners in different organisms, bioinformatics approaches will probably not reveal additional RCT domains. Therefore, our structural-functional studies provide a foundation for the study of the RCT domains of additional RAP1 proteins.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METhODS
Protein expression and purification. Human TRF2 RBM -RAP1 RCT complex. Human TRF2 RBM (residues 275-316) was cloned into a GST fusion protein expression vector, pGEX6p-1 (GE Healthcare), and RAP1 RCT (residues 303-399) into a modified pET28b vector with a Sumo protein fused at the N terminus after the His 6 tag 41 . The TRF2 RBM -RAP1 RCT complex was coexpressed in Escherichia coli BL21(DE3) and purified by tandem affinity steps (Ni-NTA agarose beads and glutathione Sepharose beads). Ulp1 and 3C proteases were added to remove the His 6 -Sumo and GST tags, respectively. Finally, the TRF2 RBM -RAP1 RCT complex was further purified by gel-filtration chromatography. The SeMet-substituted complex was similarly purified.
Fission yeast SpRap1 RCT -Taz1 RBM fusion protein. To facilitate protein purification and structure determination, we made a fusion protein construct that contains SpRap1 RCT (residues 639-693), a 14-residue linker (N-GGSGGSKLGGSG GS-C) and Taz1 RBM (residues 362-395). The SpRap1 RCT -Taz1 RBM fusion protein was cloned into the modified pET28b vector 41 . The protein was expressed in E. coli BL21(DE3). M9 minimal media supplemented with 15 15 N-and 13 C-labeled proteins, respectively. The proteins were purified by Ni-NTA affinity chromatography. The Sumo-tag was removed by on-column cleavage with Ulp1 and the proteins were further purified by gel-filtration chromatography.
Budding yeast Sir3 RBM -ScRap1 RCT complex. Sir3 RBM (residues 456-481) was cloned into GST fusion protein expression vector pGEX6p-1 and ScRap1 RCT (residues 679-827) was cloned into the modified pET28b vector 41 . The Sir3 RBMScRap1 RCT complex was coexpressed in E. coli BL21(DE3). The purification procedure is the same for the human TRF2 RBM -RAP1 RCT complex as described above except for the last step. Owing to the relatively weak interaction between Sir3 RBM and ScRap1 RCT , some of the Sir3 RBM peptides were lost during the purification process. Thus, in the final gel-filtration chromatography step we mixed additional individually purified Sir3 RBM peptides with the complex to make sure that there were enough Sir3 RBM peptides in the final sample.
Proteins used in the in vitro ITC experiments. For the ITC assays, wild-type and mutant RAP1 RCT , SpRap1 RCT , ScRap1 RCT , TRF2 RBM , Taz1 RBM and Sir3 RBM were cloned into the modified pET28b vector 41 . They were purified according to the procedure described above, except that only Ni-NTA affinity step was used.
Crystallization, data collection and structure determination. Human TRF2 RBM -RAP1 RCT complex. The TRF2 RBM -RAP1 RCT complex was crystallized by hanging-drop vapor diffusion at 4 °C. The precipitant solution contained 100 mM sodium citrate, pH 5.2, 17% (v/v) PEG 2000, 16% (v/v) isopropanol and 10 mM DTT. Crystals were gradually transferred to a harvesting solution (precipitant solution and 20% (v/v) glycerol) before being flash-frozen in liquid nitrogen. SeMet-SAD (at selenium peak wavelength 0.9785 Å) data set with a resolution of 1.95 Å was collected at beam line 21ID-D at APS and processed using HKL2000 (ref. 42) . SAD phases were calculated using SHARP 43 . A model was automatically built into the solvent-flattening modified experimental electron density using ARP/WARP 44 ; the model was then further refined in CNS 45 with manual rebuilding using O 46 .
Budding yeast Sir3 RBM -ScRap1 RCT complex. The Sir3 RBM -ScRap1 RCT complex was crystallized by hanging-drop vapor diffusion at 4 °C. The precipitant solution contained 100 mM sodium citrate, pH 4.8, 30% (v/v) PEG4K, 200 mM ammonium acetate and 10 mM DTT. Crystals were gradually transferred to a harvesting solution (precipitant solution and 20% (v/v) glycerol). A native data set with a resolution of 2.0 Å was collected at beamline 21ID-D at APS and processed using HKL2000 (ref. 42) . The structure was determined by molecular replacement using Phaser in the CCP4i suite 47 and the crystal structure of ScRap1 RCT (PDB 3CZ6) as the initial model. The Sir3 RBM fragment was manually built into the electron density using O 46 and then further refined in CNS 45 .
NMR spectroscopy and structure determination of fission yeast Taz1 RBMSpRap1 RCT complex. The NMR experiments were carried out at 25 °C on Bruker 600-and 800-MHz spectrometers equipped with four RF channels and tripleresonance pulsed-field gradient cryoprobes. All NMR spectra were processed with NMRPipe 48 and analyzed with Sparky. Initial structures were calculated using ARIA 2.2 (ref. 49) , NOE peaks were assigned with SANE 50 and CYANA 2.1 (ref. 51 ) and the final structures were refined with Amber 9.0 (ref. 52 ). The 20 refined structures with the lowest energy were analyzed using PROCHECK-NMR 53 .
Isothermal titration calorimetry. The K d values of the TRF2 RBM -RAP1 RCT , the Taz1 RBM -SpRap1 RCT and the Sir3 RBM -ScRap1 RCT interactions were determined by using a VP-ITC calorimeter (MicroCal). ITC data were analyzed and fit using Origin 7 (OriginLab).
Yeast two-hybrid assay. Yeast two-hybrid assays were carried out using L40 strains harboring pBTM116 and PACT2 (Clontech) fusion plasmids and selected on plates without leucine or tryptophan . β-galactosidase activities were measured according to Clontech MATCHMAKER library protocol and the averages from three individual transformants were reported.
Coimmunoprecipitation. Cells (293T) were transiently transfected using lipofectamine 2000 (Invitrogen) following the manufacturer's protocol. Cells were lysed and supernatants were used for immunoprecipitation with agarose beads conjugated with antibody to Myc (Sigma). Beads were washed four times and then proteins were eluted and analyzed by SDS-PAGE.
shRNA sequence. The mouse Trf2 shRNA targeting sequence 5′-GAACAGCT GTGATGATAA-3′ was cloned into pRetro-Super vector (Stratagene) and used as described in the text.
Generation of MEFs and retroviral infection of cell lines.
Primary MEFs isolated from embryonic day (E) 13.5 were immortalized at passage 2 by transfection with pBabeSV40LT. Trf2 shRNA was generated in pSuper as described 25 . Cells (293T) were transiently transfected with shRNA-resistant DNA constructs for viral particle packaging using Lipofectamine Plus (Invitrogen). Viral supernatant was collected 48-72 h after transfection, filtered through 0.45-µm pore-size membrane and directly used to infect the SV40LT-immortalized MEFs. MEFs infected with shRNA-resistant cDNAs were further infected by two consecutive rounds of Trf2 shRNA at 12-h intervals. After 4 d of infection, cells selected in puromycin were harvested for chromosome analysis.
Immunoblotting. Cell extracts were isolated and western blot was carried out as described 25 . We obtained antibody to Chk2 from BD Biosciences, antibody to Flag from Sigma, antibodies to γ-tubulin, Myc and hemagglutinin from Santa Cruz, antibody to γH2AX from Upstate, antibody to RAP1 from Abcam, antibody to GFP from Clontech and antibody to TRF2 from J. Karlseder; antibody to SpRap1 was raised to recognize the C-terminal 324 residues of SpRap1 (ref. 29) .
Transient transfection of HeLa cells. HeLa cells grown on coverslips were transiently transfected with DNA using fugene 6 (Roche) following the manufacturer's protocol. After 48 h of transfection the cells were fixed and subjected to immunofluorescence and fluorescent in situ hybridization (IF-FISH) analysis.
Immunofluorescence and fluorescent in situ hybridization. Cells grown on coverslips were fixed for 10 min in 2% (w/v) sucrose and 2% (v/v) paraformaldehyde at room temperature followed by PBS washes. Coverslips were blocked for 1 h in blocking solution (0.2% (w/v) fish gelatin and 0.5% (w/v) BSA in 1× PBS). The cells were incubated with primary antibodies (antibodies to HA and Myc for HeLa cells; antibodies to γ-H2AX, Trf2 and Rap1 for MEFs) for 2 h at room temperature. After PBS washes, coverslips were incubated with the appropriate Alexa fluor secondary antibody for 1 h followed by washes in PBS. IF-FISH was carried out as described 25 using a 5′-Tam-OO-(CCCTAA) 4 -3′ PNA telomere probe (Applied Biosystems). DNA was counterstained with 4,6-diamidino-2-phenylindole (DAPI) and slides were mounted in 90% (v/v) glycerol and 10% (w/v) PBS containing 1 µg ml −1 p-phenylene diamine (Sigma). Digital images were captured with a Nikon Eclipse 800 microscope.
Chromosomal analysis. Metaphase chromosomes from MEFs were prepared 4 to 7 h after colcemid treatment. Chromosomes were fixed and telomere FISH with the PNA probe (Applied Biosystems) was carried out as described 25 .
